A Multicenter, Dose-finding Study to Determine if Oral BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in Elderly Subjects
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 08 Nov 2018
At a glance
- Drugs Dactolisib (Primary) ; Everolimus (Primary)
- Indications Respiratory tract infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors resTORbio
- 08 Nov 2018 Results presented in a resTORbio media release.
- 08 Nov 2018 According to a resTORbio media release, data from the study will be presented The Gerontological Society of America 2018 Annual Scientific Meeting (GSA 2018).
- 16 Oct 2018 According to a resTORbio media release, detailed results will be submitted for presentation at an upcoming medical meeting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History